Innovations in optometry are accelerating, and one breakthrough emerging from Optometry’s Meeting® 2025 is turning heads: 3D-printed contact lenses infused with medication. These lenses present a futuristic yet practical approach to treating common eye conditions and transforming patient convenience.
Developed by MediPrint Ophthalmics, these contact lenses are created using advanced 3D printing and infused with therapeutic agents such as hyaluronic acid—commonly used for lubrication and hydration. The design offers a wearable delivery system for medications treating conditions like glaucoma, allergies, and post-surgical discomfort.
Enhanced Compliance: Goodbye to missed drops — patients get consistent doses simply by wearing lenses.
Precision Delivery: Medication is released directly on the eye, potentially increasing effectiveness and reducing systemic side effects.
A New Standard in Eye Care: This technology blends comfort with therapeutics, positioning it as an innovative tool for optometric practices looking to elevate patient care.
The Innovation Hub at this year’s AOA meeting also spotlighted other emerging treatments like oral therapies for presbyopia and age-related eye diseases. Together, these advancements are driving the industry toward more integrated, medical-centered eyecare models.